Watanabe, R., Teague, J. E., Fisher, D. C., Kupper, T. S., & Clark, R. A. (2014). Alemtuzumab therapy for leukemic CTCL: Diffuse erythema as a positive predictor of complete remission.
Citação norma ChicagoWatanabe, Rei, Jessica E. Teague, David C. Fisher, Thomas S. Kupper, and Rachael A. Clark. Alemtuzumab Therapy for Leukemic CTCL: Diffuse Erythema As a Positive Predictor of Complete Remission. 2014.
Citação norma MLAWatanabe, Rei, et al. Alemtuzumab Therapy for Leukemic CTCL: Diffuse Erythema As a Positive Predictor of Complete Remission. 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.